In biotech, here are the top 10 news stories of the year so far, based on web traffic.
Welcome to the latest edition of our weekly EuroBiotech Report.
November is Diabetes Awareness Month. So many people have heard of diabetes, but yet so few really understand the disease. So this month the Juvenile Diabetes Research Foundation (JDRF) and the American Diabetes Association (ADA), two advocacy organizations for people with diabetes, are sharing stories (and raising awareness) to help people better understand this complicated disease.
Five years ago my daughter Eva was diagnosed with Type 1 diabetes, which is a very different form of the disease than the more common form known as Type 2. Type 1 diabetes is an autoimmune disease for which there is no cure. It doesn’t come as a result of bad diet or lack of exercise. There is nothing that can be done to prevent it. And there is no such thing as growing out of it. And it doesn’t get better with diet and exercise. It is simply managed through multiple daily injections of insulin (a wonderful biotechnology discovery).
As dreadful as this disease can be, we are thankful that there is so much research and work being done by biotech companies to find better ways to treat – and hopefully cure – this disease. In my time at BIO I have had the privilege of meeting some of the men and women who work hard every day to make that a reality, and there are many hopeful signs on the horizon. But as one Harvard scientist said recently, “We’re tired of curing mice.”
So with that, I am doing my part as a member of the JDRF community, and sharing an article and brief video put out recently by JDRF to help make people more aware of diabetes, specifically Type 1. The Huffington Post has a wonderful story and a cute video about a couple little boys who battle this every day:
Thanks for reading, watching and listening. Awareness is the first step toward progress and hopefully a cure.